According to Fresenius Medical Care's latest financial reports the company has a price-to-book ratio of 0.7571.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 0.7467 | 28.84% |
2022-12-31 | 0.5795 | -51.77% |
2021-12-31 | 1.20 | -25.13% |
2020-12-31 | 1.60 | 8.21% |
2019-12-31 | 1.48 | 10.11% |
2018-12-31 | 1.35 | -45.64% |
2017-12-31 | 2.48 | 11.5% |
2016-12-31 | 2.22 | -8.7% |
2015-12-31 | 2.43 | 9.02% |
2014-12-31 | 2.23 | -2.93% |
2013-12-31 | 2.30 | -0.18% |
2012-12-31 | 2.30 | -10.05% |
2011-12-31 | 2.56 | 10.93% |
2010-12-31 | 2.31 | 0.14% |
2009-12-31 | 2.31 | 2.65% |
2008-12-31 | 2.25 | -18.78% |
2007-12-31 | 2.77 | 5.81% |
2006-12-31 | 2.61 | 1.25% |
2005-12-31 | 2.58 | 67.7% |
2004-12-31 | 1.54 | 2.26% |
2003-12-31 | 1.51 | 52.77% |
2002-12-31 | 0.9856 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Amgen AMGN | 32.2 | 4,146.87% | ๐บ๐ธ USA |
Baxter BAX | 2.07 | 173.24% | ๐บ๐ธ USA |
DaVita DVA | 4.90 | 546.64% | ๐บ๐ธ USA |
IDEXX Laboratories IDXX | 26.3 | 3,374.95% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | 2.36 | 212.33% | ๐บ๐ธ USA |
Teleflex TFX | 2.16 | 185.50% | ๐บ๐ธ USA |
LabCorp LH | 2.04 | 170.07% | ๐บ๐ธ USA |
Rockwell Medical
RMTI | 2.63 | 247.22% | ๐บ๐ธ USA |